Nexus
XTRA:NXU
71,30
€0,00 (0,00%)
71,30
€0,00 (0,00%)
End-of-day quote: 11/24/2025

Nexus Stock Value

Analysts currently rate Nexus as sf_data unavailable.
-

Nexus Company Info

EPS Growth 5Y
21,00%
Market Cap
€1,23 B
Long-Term Debt
€0,00 B
Annual earnings
N/A
Dividend
€0,00
Dividend Yield
0,00%
Founded
1989
Industry
Country
Website
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Nexus’s Price Target has risen from €70,00 to €70,00 - a 0,00% increase. One analysts predict that Nexus’s share price will fall in the coming year, reaching €0,00. This would represent a decrease of -100,00%.

Top growth stocks in the health care sector (5Y.)

What does Nexus do?

Nexus AG develops and sells software solutions for the international healthcare market. Business Segments Nexus AG primarily operates within the healthcare software industry, focusing on delivering advanced digital solutions that address a broad spectrum of needs within healthcare organizations. The company’s primary business segment is centered on its robust Hospital Information System (NEXUS / HIS), which includes a range of integrated modules designed to enhance the functionalities of healt...
×